|
| | SR0236 | | LRB101 11593 MST 57605 r |
|
|
1 | | SENATE RESOLUTION
|
2 | | WHEREAS, Pediatric acute-onset neuropsychiatric syndrome |
3 | | (PANS) and pediatric autoimmune neuropsychiatric disorder |
4 | | associated with streptococcal infection (PANDAS) create the |
5 | | sudden onset of obsessive-compulsive disorder in children, |
6 | | causing previously healthy and emotionally adjusted children |
7 | | to experience severe anxiety and emotional disturbances; and
|
8 | | WHEREAS, Children with PANS and PANDAS tend to manifest |
9 | | some of the following symptoms: tics or other abnormal |
10 | | movements, severe separation anxiety, generalized anxiety, |
11 | | irritability, aggression, personality changes, ADHD, marked |
12 | | deterioration in learning and school performance, and |
13 | | developmental regression, including deterioration in |
14 | | handwriting; and
|
15 | | WHEREAS, PANS is broader than PANDAS as it includes not |
16 | | only disorders associated with a preceding infection, such as |
17 | | Mycoplasma Pneumoniae, Mono, Lyme, viruses, and more, but also |
18 | | acute onset non-infectious triggers, such as environmental |
19 | | factors and metabolic dysfunction; treatment plans similar to |
20 | | those for PANDAS should be attempted; and
|
21 | | WHEREAS, Children with PANS and PANDAS may experience |
22 | | moderate to dramatic improvement with antibiotics, steroids, |